A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study

PHASE2CompletedINTERVENTIONAL
Enrollment

611

Participants

Timeline

Start Date

September 26, 2012

Primary Completion Date

March 25, 2016

Study Completion Date

March 25, 2016

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

peficitinib

oral

Trial Locations (51)

1027

Site HU3302, Budapest

Site HU3448, Budapest

Site HU3462, Budapest

1070

Site BE3387, Brussels

1190

Site BE3314, Brussels

1612

Site BG3303, Sofia

4003

Site BG3217, Plovdiv

5600

Site HU3398, Békéscsaba

6700

Site MX3310, México

8000

Site BG3613, Burgas

8230

Site HU3461, Balatonfüred

16635

Site US345, Duncansville

19610

Site US3304, Wyomissing

20902

Site US291, Wheaton

23320

Site US3327, Chesapeake

26301

Site US3320, Clarksburg

28602

Site US3298, Hickory

32216

Site US1894, Jacksonville

32804

Site US3232, Orlando

35216

Site US3218, Birmingham

37909

Site US3306, Knoxville

42701

Site US3329, Elizabethtown

44280

Site MX3307, Guadalajara, Jalisco

44650

Site MX3238, Guadalajara

58070

Site MX3317, Morelia

60053

Site US702, Morton Grove

60061

Site US3226, Vernon Hills

68601

Site CZ3225, Uherské Hradiště

73103

Site US3300, Oklahoma City

78705

Site US3319, Austin

80920

Site US3331, Colorado Springs

92260

Site US3227, Palm Desert

93454

Site US3332, Santa Maria

94304

Site US219, Palo Alto

92093-0943

Site US828, La Jolla

Unknown

Site CO3326, Barranquilla, Atlantico

Site CO3297, Bogotá

Site CO2826, Bucamaranga

Site CO3450, Bucaramanga

Site CO3451, Santiago de Cali

128 50

Site CZ3388, Prague

140 00

Site CZ3376, Praha-Nusle

760 01

Site CZ3449, Zlín

H-4043

Site HU3447, Debrecen

15-351

Site PL3233, Bialystok

15-879

Site PL3391, Bialystok

85-168

Site PL2893, Bydgoszcz

31-637

Site PL3603, Krakow

20-582

Site PL3601, Lublin

02-118

Site PL3600, Warsaw

02-653

Site PL3599, Warsaw

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Janssen Biotech, Inc.

INDUSTRY

lead

Astellas Pharma Global Development, Inc.

INDUSTRY